SalesSparx and Augment Release SAMI.ai for Healthcare Sales Teams
SalesSparx and Augment announced in a press release the general release of SAMI.ai, an AI sales performance system for healthcare sales teams.
SAMI.ai applies healthcare sales intelligence to sales conversations and deal reviews. The system checks how each deal is progressing, flags missed questions and hidden risks, and suggests next actions for moving an opportunity forward.
The release follows more than 12 months of use with SalesSparx clients. The companies said SAMI.ai combines Augment workflow orchestration with SalesSparx healthcare sales expertise from more than 100 healthcare B2B engagements and a decade of sales research.
SalesSparx is also offering a free deal review tied to measurable outcomes for healthcare software, technology, and services companies with revenue between $5 million and $100 million.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, Sales & Marketing AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 17 Masimo Gets FDA Clearance for AFib Detection on Radius VSM Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflowsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Symbe Raises $5.7 Million for AI Sales Platform
Sainaptic Raises £1 Million for AI Assisted Assessment Tools
The Saffron Solution Brings AI Workflow Tools to AAO 2026
Prosper AI Estimates $108 Billion Revenue Opportunity for Specialty Practices
AdminaHealth Adds AI Data Assistant to Enterprise Billing Suite
Daily AI Brief: the AI news that matters, in your inbox.